Opportunity Information: Apply for RFA GD10 001
Apply for RFA GD10 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Knowledge Synthesis Center for Evaluating Genomic Application in Practice and Prevention (U18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.068 Chronic Diseases Research, Control, and Prevention.
- This funding opportunity was created on Apr 9, 2010 and posted on Feb 3, 2010.
- Applicants must submit their applications by Apr 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments For profit organizations other than small businesses Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Private institutions of higher education City or township governments Small businesses.
- Public nonprofit organizations Private nonprofit organizations For profit organizations Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, you must provide a letter from the state or local government as documentation of your status. Attach this documentation behind the first page of your application form or for electronic applications, use a PDF file and attach as Other Documents and label as appropriate.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Knowledge Synthesis Center for Evaluating Genomic Application in Practice and Prevention (U18)" (Funding Opportunity Number RFA GD10 001), was a CDC cooperative agreement designed to support a single, centralized effort to pull together and evaluate what is known about how genomics can be used in real-world public health practice and disease prevention. It was issued by the Centers for Disease Control and Prevention (CDC) within HHS, specifically through the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). The basic idea behind the announcement was to create or support a "knowledge synthesis" function, meaning a dedicated group that would systematically review, organize, and interpret existing scientific and program evidence so public health agencies and partners could make better decisions about genomic applications that might be ready (or not ready) for use in practice.
The opportunity was explicitly tied to federal performance and accountability expectations. NCCDPHP emphasized its commitment to achieving Healthy People 2010 objectives and to measuring program performance under the Government Performance and Results Act (GPRA). In practical terms, that framing signals that the work funded under this cooperative agreement was expected to do more than produce academic publications. The center would be expected to generate usable, policy- and practice-relevant syntheses that could help CDC and public health programs track progress, prioritize interventions, and justify decisions using evidence, especially in areas where genomic science was moving quickly but implementation guidance was uneven.
Programmatically, the announcement was broad in terms of the health topics it connected to. It referenced a wide range of Healthy People 2010 priority areas, including arthritis, cancer, kidney disease, diabetes, disability, heart disease and stroke, HIV, infectious diseases, maternal and child health, mental health, overweight, respiratory diseases, substance abuse, tobacco use, vision and hearing, educational and community-based programs, and public health infrastructure. That scope suggests the knowledge synthesis center was not meant to sit inside a single disease silo. Instead, it was positioned to evaluate cross-cutting genomic applications that could influence prevention, screening, risk assessment, or targeted interventions across multiple chronic and infectious disease domains, as well as broader public health systems and community programs.
From a funding and administrative standpoint, this was a discretionary award using a cooperative agreement mechanism (U18). A cooperative agreement generally means CDC anticipated substantial involvement with the awardee, such as collaboration on priorities, methods, deliverables, or dissemination, rather than simply issuing a grant and stepping back. The total estimated funding listed for the opportunity was $500,000, and the announcement anticipated making one award. The notice also indicated a cost sharing or matching requirement, meaning the recipient would need to contribute resources toward the project in addition to federal funds, consistent with the terms described in the full announcement.
Eligibility was intentionally expansive, covering many types of organizations that could credibly operate a national-level evidence synthesis and translation function. Eligible applicants included public and private nonprofits, for-profit organizations (including small businesses and small/minority/women-owned businesses), universities and colleges (public and private), research institutions, hospitals, community-based and faith-based organizations, and a wide range of government entities. The eligibility list also specifically included federally recognized or state recognized American Indian/Alaska Native tribal governments and tribally connected organizations, Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers. State and local governments and their bona fide agents were eligible as well, with the important administrative note that a bona fide agent application required documentation (a letter from the state or local government) attached to the application.
Key dates show this was a time-limited, archived opportunity from 2010. It was posted February 3, 2010, with an original and current closing date of April 7, 2010, and an archive date of May 7, 2010. The CFDA number associated with the opportunity was 93.068 (Chronic Diseases Research, Control, and Prevention), aligning it with CDC efforts around chronic disease prevention and evidence-based public health action, even though the topic focus was genomics as an enabling area.
For applicants or stakeholders who needed help accessing the full announcement, the contact listed was CDC/PGO TIMS (Technical Information Management Section) at 770-488-2700. Overall, the opportunity aimed to fund a single, coordinated center that could help CDC and partners make evidence-based judgments about which genomic applications were appropriate for public health practice and prevention, and how those applications fit into national prevention priorities and performance goals.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Knowledge Synthesis Center for Evaluating Genomic Application in Practice and Prevention (U18)."
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA GD10 001.
Which federal agency issued this funding opportunity?
This was issued by the Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services (HHS).
Which CDC center was responsible for this opportunity?
The opportunity was issued through CDC's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP).
What is the primary purpose of the award?
The purpose was to support a single, centralized "knowledge synthesis" effort that would pull together and evaluate what is known about using genomics in real-world public health practice and disease prevention.
What does "knowledge synthesis" mean in this announcement?
In this context, "knowledge synthesis" refers to a dedicated function or group that would systematically review, organize, and interpret existing scientific and program evidence so public health agencies and partners could make better decisions about genomic applications.
How many awards were expected to be made?
The announcement anticipated making one award.
What is the award mechanism (grant type)?
This was a cooperative agreement using the U18 mechanism.
What does a cooperative agreement imply for how CDC would work with the recipient?
A cooperative agreement generally indicates CDC anticipated substantial involvement with the awardee, such as collaborating on priorities, methods, deliverables, or dissemination, rather than simply providing funds with minimal federal engagement.
How much funding was available under this opportunity?
The total estimated funding listed for the opportunity was $500,000.
Was cost sharing or matching required?
Yes. The notice indicated there was a cost sharing or matching requirement, meaning the recipient would need to contribute resources toward the project in addition to federal funds, consistent with the terms described in the full announcement.
What kinds of results were expected from the funded center?
The framing in the announcement emphasized usable, policy- and practice-relevant syntheses, not just academic publications. The work was positioned to help CDC and public health programs track progress, prioritize interventions, and justify decisions using evidence, especially in areas where genomic science was moving quickly but implementation guidance was uneven.
How was the opportunity tied to federal performance and accountability expectations?
NCCDPHP linked the work to Healthy People 2010 objectives and to measuring program performance under the Government Performance and Results Act (GPRA), signaling an expectation for practical outputs that support performance measurement and evidence-based decision-making.
What health topics or program areas were included in the scope?
The announcement referenced many Healthy People 2010 priority areas, including arthritis, cancer, kidney disease, diabetes, disability, heart disease and stroke, HIV, infectious diseases, maternal and child health, mental health, overweight, respiratory diseases, substance abuse, tobacco use, vision and hearing, educational and community-based programs, and public health infrastructure.
Was the center intended to focus on a single disease area?
No. The scope suggested the center was not meant to sit inside a single disease silo. It was positioned to evaluate cross-cutting genomic applications relevant to prevention, screening, risk assessment, or targeted interventions across multiple chronic and infectious disease domains, as well as broader public health systems and community programs.
Who was eligible to apply?
Eligibility was broad. Eligible applicants included public and private nonprofits, for-profit organizations (including small businesses and small/minority/women-owned businesses), universities and colleges (public and private), research institutions, hospitals, community-based and faith-based organizations, and a wide range of government entities.
Were tribal governments and tribally connected organizations eligible?
Yes. The eligibility list specifically included federally recognized or state recognized American Indian/Alaska Native tribal governments and tribally connected organizations, Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers.
Were state and local governments eligible?
Yes. State and local governments and their bona fide agents were eligible.
If applying as a bona fide agent of a state or local government, was documentation required?
Yes. A bona fide agent application required documentation (a letter from the state or local government) attached to the application.
What were the key dates for this funding opportunity?
It was posted February 3, 2010. The original and current closing date was April 7, 2010. The archive date was May 7, 2010.
Is this an active opportunity?
No. Based on the dates provided (including the archive date of May 7, 2010), this was a time-limited, archived opportunity from 2010.
What CFDA number was associated with this opportunity?
The CFDA number was 93.068 (Chronic Diseases Research, Control, and Prevention).
How does the CFDA alignment relate to the genomics focus?
The CFDA alignment placed the opportunity within CDC efforts around chronic disease prevention and evidence-based public health action, while the specific topic focus was genomics as an enabling area for practice and prevention decisions.
Who was listed as a contact for help accessing the full announcement?
The contact listed was CDC/PGO TIMS (Technical Information Management Section) at 770-488-2700.
What was the overall intended impact of funding a single knowledge synthesis center?
The overall intent was to fund one coordinated center that could help CDC and partners make evidence-based judgments about which genomic applications were appropriate for public health practice and prevention, and how those applications fit into national prevention priorities and performance goals.
Browse more opportunities from the same category: Health
Next opportunity: Data Collection and Support Services for Malawis Agricultural Development Program Support Projects Impact Evaluation
Previous opportunity: Scientific Meetings for Creating Interdisciplinary Research Teams (R13)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GD10 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GD10 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers of Research Translation (P50) Apply for RFA AR 11 002 Funding Number: RFA AR 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| National Environmental Public Health Tracking Program National Association for Health Data Organizations Apply for CDC RFA EH10 1003 Funding Number: CDC RFA EH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change Finding Mechanisms of Change in the Laboratory and the Field (R01) Apply for RFA RM 10 002 Funding Number: RFA RM 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Center for Chronic Disease Prevention and Health Promotion Conference Support Program Apply for CDC RFA DP10 1005 Funding Number: CDC RFA DP10 1005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Knowledge to Practice Apply for HRSA 10 086 Funding Number: HRSA 10 086 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening National HIV/AIDS Training Systems in the Republic of Uganda, Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1022 Funding Number: CDC RFA PS10 1022 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,900,000 |
| Improving the Availability of Safe Blood Transfusion Services through a Quality Management System in the Federal Republic of Nigeria, under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1040 Funding Number: CDC RFA PS10 1040 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Capacity Building and Technical Assistance for the Tanzania Interfaith Partnership (TIP) Networks and Leaders to Enhance HIV/AIDS Prevention and Community Care in the United Republic of Tanzania under the United Republic of Tanzania under (PEPFAR) Apply for CDC RFA PS10 1061 Funding Number: CDC RFA PS10 1061 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Cooperative Agreement with the Kenya Medical Research Institute (KEMRI) Apply for CDC RFA GH10 1001 Funding Number: CDC RFA GH10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $32,616,995 |
| Conducting Public Health Research in Kenya (U01) Apply for RFA GH 10 003 Funding Number: RFA GH 10 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,250,000 |
| Surveillance, Natural History, Quality of Care and Outcomes of Diabetes Mellitus with Onset in Childhood and Adolescence (U 18) Apply for RFA DP10 001 Funding Number: RFA DP10 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening HIV Strategic Health Management Information System (HMIS) Activities in the United Republic of Tanzania to Improve Informatics and Data Use within the Health Sector under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1066 Funding Number: CDC RFA PS10 1066 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Support for Strengthening and Expanding Comprehensive HIV and AIDS Prevention Programs in the Republic of South Africa Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1049 Funding Number: CDC RFA PS10 1049 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| HIV/AIDS Prevention through Mass Media and Social Mobilization in the Republic of South Africa Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10118 Funding Number: CDC RFA PS10 10118 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Support for the Greater Involvement of People Living with HIV/AIDS (GIPA) in the Federal Democratic Republic of Ethiopia Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10158 Funding Number: CDC RFA PS10 10158 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Strengthening Care and Support Services for Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cte d Ivoire Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1029 Funding Number: CDC RFA PS10 1029 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,000,000 |
| Technical Assistance for Strategic Information Activities in the Republic of Mozambique Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1082 Funding Number: CDC RFA PS10 1082 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Improving uptake of Preventing Mother to Child Transmission (PMTCT) services through establishment of community based PMTCT programs in Nigeria Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1072 Funding Number: CDC RFA PS10 1072 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Strengthening HIV/AIDS Prevention and Care Services for Highly Vulnerable Populations in the Republic of Cte d Ivoire Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1031 Funding Number: CDC RFA PS10 1031 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Effective HIV Prevention and Enhanced HIV/AIDS Community Care through Tanzanian Interfaith Networks and Religious Leadership Support in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1060 Funding Number: CDC RFA PS10 1060 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GD10 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.